Propel Bio Management, LLC 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Propel Bio Management, LLC disclosed 21 US equity positions worth $172.4m in its Q3 2024 13F filing. The largest position was APLT at 32.4% of the reported book, followed by PAGPEUR and PHAT.
What did Propel Bio Management, LLC own in Q3 2024? Top 21 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | APLT APPLIED THERAPEUTICS INC | 32.4% | $55.8m | 6,567,858 | – | ||
| 2 | PAGPEUR PLAINS GP HOLDINGS LP-CL | 13.7% | $23.5m | 1,272,360 | – | ||
| 3 | PHAT PHATHOM PHARMACEUTICALS I | 9.1% | $15.7m | 869,927 | – | ||
| 4 | ACHV ACHIEVE LIFE SCIENCES INC | 6.7% | $11.6m | 2,453,092 | – | ||
| 5 | TCRX TSCAN THERAPEUTICS INC | 6.0% | $10.4m | 2,087,139 | – | ||
| 6 | AKERO THERAPEUTICS INC | 5.7% | $9.9m | 343,729 | – | ||
| 7 | MDGL MADRIGAL PHARMACEUTICALS | Healthcare | 5.3% | $9.1m | 43,032 | – | |
| 8 | RNAGBP AVIDITY BIOSCIENCES INC | 4.8% | $8.2m | 178,500 | – | ||
| 9 | ARDX ARDELYX INC | Healthcare | 4.3% | $7.4m | 1,070,947 | – | |
| 10 | TSAT TELESAT CORP | 2.8% | $4.8m | 365,781 | – | ||
| 11 | ABEO ABEONA THERAPEUTICS INC | Healthcare | 2.3% | $3.9m | 624,022 | – | |
| 12 | KYMR KYMERA THERAPEUTICS INC | Healthcare | 1.5% | $2.7m | 56,359 | – | |
| 13 | SNDX SYNDAX PHARMACEUTICALS IN | Healthcare | 1.5% | $2.6m | 133,259 | – | |
| 14 | KURA KURA ONCOLOGY INC | Healthcare | 1.5% | $2.5m | 130,000 | – | |
| 15 | ZVRA ZEVRA THERAPEUTICS INC | 0.7% | $1.2m | 179,874 | – | ||
| 16 | 72C EIGER BIOPHARMACEUTICALS | 0.7% | $1.2m | 146,381 | – | ||
| 17 | ATHIRA PHARMA INC | 0.4% | $665.8k | 1,492,792 | – | ||
| 18 | CMPS COMPASS PATHWAYS LTD | Healthcare | 0.3% | $504.0k | 80,000 | – | |
| 19 | VRCA VERRICA PHARMACEUTICALS I | 0.3% | $500.2k | 344,937 | – | ||
| 20 | MAAT PHARMA SACA | 0.0% | $17.8k | 2,397 | – | ||
| 21 | CHINOOK THERAPEUTICS | 0.0% | $9.8k | 79,357 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.